• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.64% Nasdaq Down 0.55%

    More On AMBI

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Ambit Biosciences Corporation (AMBI)

    -NasdaqGM
    15.60 0.00(0.00%) Nov 10, 4:00PM EST
    Add to Portfolio
    Prev Close:15.60
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:14.00
    Beta:8.733
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:4.99 - 64.00
    Volume:0
    Avg Vol (3m):1,579
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-1.57
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AMBI

    Comparison

    Symbol% ChgMkt Cap
    AMBI 0.00%N/A
    BAYRYDown 2.42%N/A
    ONXX 0.00%N/A
    PFEUp 0.90%213.98B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :N/A
    Quarterly EPS Est (Sep-14) :N/A
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ambit Biosciences Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of oncology, autoimmune, and inflammatory diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback